Highlights in USP7 inhibitors for cancer treatment
Ubiquitin-specific protease 7 (USP7) is a member of one of the most largely studied families of deubiquitylating enzymes. It plays a key role modulating the levels of multiple proteins, including tumor suppressors, transcription factors, epigenetic modulators, DNA repair proteins, and regulators of...
Main Authors: | Rita I. Oliveira, Romina A. Guedes, Jorge A. R. Salvador |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fchem.2022.1005727/full |
Similar Items
-
Role of Ubiquitin-Specific Peptidase 47 in Cancers and Other Diseases
by: Kailing Pan, et al.
Published: (2021-09-01) -
USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation
by: Christophe Le Clorennec, et al.
Published: (2023-09-01) -
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
by: Keqiang Zhang, et al.
Published: (2023-11-01) -
USP7 Promotes deubiquitination and stabilization of MyD88 to enhance immune responses
by: Na Zhang, et al.
Published: (2022-08-01) -
The USP7 protein interaction network and its roles in tumorigenesis
by: Ahood Al-Eidan, et al.
Published: (2022-01-01)